 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Proteus Digital Health |
| Street 1: | 2600 Bridge Parkway |
| Street 2: | |
| City: | REDWOOD CITY |
| Province: | CA |
| Post Code: | 94065 |
| Country: | United States of America |
| Phone: | (650) 632-4031 |
| Organization Email: | splowman@proteus.com |
| Web Site: | http://www.proteus.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| Armed with more than 450 issued patents and led by some of the brightest minds in technology, pharmaceuticals and healthcare, we’ve invented Digital Medicine, a new category of pharmaceuticals that measures medication treatment effectiveness, helps physicians improve clinical outcomes and patients reach health goals. Together, with leading health systems and pharmaceutical companies, we’re bringing this new digital solution to healthcare providers, thereby increasing access to better insight, optimized therapies and lower costs. Digital Medicines form the backbone of Wirelessly Observed Therapy (WOT) which has been used extensively in the treatment of TB and has been proven in randomized controlled trials to confirm 54% more doses than DOT, at approximately half the cost. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Civil Society and Community Engagement Delivery of health services and care Provision of drugs, diagnostics and commodities Technical Assistance Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 11 - 25 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | Jackie Huh |
| Why do you wish join the Stop TB Partnership: | Resource mobilization |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| We are actively working with some of the United States' most prominent TB academics and researchers as well as with several counties where the TB burden in the US is greatest. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
United States of America |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: We would like to begin work in many nations where TB burden is highest. We have direct plans and preparations in place to begin in South Africa, and are seeking some funding to get the work going Drug-Resistant TB: Actively working with drug manufacturers to hopefully digitize key MDR drugs. TB-HIV: We have 3 NIH -sponsored clinic trials currently enrolling in HIV New TB Drugs: Actively working with drug manufacturers to hopefully digitize key MDR drugs. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | October 18, 2018 |
| Last updated: | October 19, 2018 |